For the prevention of and response to diversion (i.e. selling or sharing of medications) or misuse (i.e. taking medication in a manner other than prescribed) of medications to treat opioid use disorder.
This website provides data and additional resources about the misuse of alcohol, tobacco, and other drugs in the United States, including data from the 2021 National Survey on Drug Use and Health (NSDUH).
These proceedings summarize the discussion from the harm reduction community roundtable and supplemental individual interviews, inclusive of representatives from national and local harm reduction organizations, state and local government agencies, tribal organizations, and researchers who have experience distributing fentanyl test strips (FTS) or are knowledgeable about FTS specifically or drug checking more generally.
This inaugural National Strategy proposes bold, targeted, and consequential actions to bend the curve on overdose deaths in the immediate term and reduce substance use and its damaging consequences in the US over the longer term.
This research report from NIDA discusses effective prevention and treatment strategies for opioid misuse and use disorder, and overcoming the misunderstandings and other barriers that prevent wider adoption of these treatments.
This NIDA policy brief shares evidence-based research on treating opioud use dissorder on pregnancy, including the assessment of methadone and buprenorphine as treatment.
This CDC page provides an overview of how opioid use impacts pregancy to help women who use opioids during pregnancy be aware of the possible risks and potential treatment options for opioid use disorder.
Email Updates